Unknown OBSERVATIONAL NCT03420131

Diagnostic Agreement of iFR and QFR. (DETECTISCHEMIA)

DETErmining the funCTional Significance of Intermediate Stenoses in isCHEMIc heArt Disease (DETECT ISCHEMIA): Diagnostic Agreement of iFR and QFR.

Sponsor: Contilia Clinical Research Institute

Conditions Coronary Artery Disease Fractional Flow Reserve, Myocardial

Interventions QFR and iFR

Updated 6 times since 2018 Last updated: Jan 27, 2018 Started: Jul 18, 2017 Primary completion: Jul 28, 2018 Completion: Oct 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03420131, this observational or N/A phase trial focuses on Coronary Artery Disease and Fractional Flow Reserve, Myocardial and remains ongoing. Sponsored by Contilia Clinical Research Institute, it has been updated 6 times since 2017, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Feb 2020 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Apr 2018 — Feb 2020 [monthly]

Recruiting

Phase: NA → None

▶ Show 1 earlier version

Mar 2018 — Apr 2018 [monthly]

Recruiting NA

First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Contilia Clinical Research Institute

Data source: Contilia Clinical Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Essen, Germany